当前位置: X-MOL 学术Addict. Behav. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Barriers and facilitators to using vaporised nicotine products as smoking cessation aids among people receiving treatment for substance use disorder
Addictive Behaviors ( IF 4.4 ) Pub Date : 2021-08-24 , DOI: 10.1016/j.addbeh.2021.107097
Alistair Lum 1 , Eliza Skelton 2 , Maryanne Robinson 3 , Ashleigh Guillaumier 2 , Olivia Wynne 4 , Coral Gartner 5 , Ron Borland 6 , Amanda Baker 2 , Adrian Dunlop 7 , Ross B Wilkinson 8 , Billie Bonevski 9
Affiliation  

Introduction

Vaporised nicotine products (VNPs) may be useful smoking cessation aids for people in alcohol and other drug (AOD) treatment, a population with high tobacco-related morbidity and mortality rates. This qualitative study aimed to examine the barriers and facilitators of using VNPs as part of a clinical trial to reduce or quit smoking among people in AOD treatment.

Methods

Thirteen people in AOD treatment who were participating in a trial of VNPs for smoking cessation (QuitENDs) completed a brief semi-structured interview examining experiences of using VNPs to reduce or quit smoking. Transcribed data was analysed using the iterative categorisation framework.

Results

Many participants expressed the benefit of having a smoking cessation aid that addressed nicotine cravings and the behavioural hand-to-mouth action to help them reduce or quit smoking. Although many participants reported that VNPs were easy to use, some found maintaining the device to be challenging. Some participants described Australian regulations limiting use of VNPs as reducing their desire to use the device as a cessation aid. Many participants attempting to reduce or quit tobacco and cannabis simultaneously stated that VNPs alone were insufficient to help them reduce or quit tobacco.

Conclusions

VNPs hold significant promise as smoking cessation aids among people in AOD treatment because of their unique ability to satisfy both nicotine cravings and behavioural habits. However, multiple barriers, such as accessibility, maintenance, and the challenges of reducing other substance use simultaneously also need to be addressed for optimal engagement in clinical trials with VNPs to quit smoking.



中文翻译:

在接受物质使用障碍治疗的人群中使用蒸发的尼古丁产品作为戒烟辅助手段的障碍和促进因素

介绍

汽化尼古丁产品 (VNP) 可能是戒烟辅助工具,适用于接受酒精和其他药物 (AOD) 治疗的人群,这些人群与烟草相关的发病率和死亡率很高。这项定性研究旨在检查在 AOD 治疗中使用 VNP 作为临床试验的一部分来减少或戒烟的障碍和促进因素。

方法

参加 VNP 戒烟试验 (QuitENDs) 的 13 名接受 AOD 治疗的人完成了一项简短的半结构化访谈,检查使用 VNP 减少或戒烟的经验。使用迭代分类框架分析转录的数据。

结果

许多参与者表达了戒烟帮助的好处,可以解决对尼古丁的渴望和行为的手到嘴行动,以帮助他们减少或戒烟。尽管许多参与者报告说 VNP 易于使用,但有些人发现维护设备具有挑战性。一些参与者将澳大利亚限制使用 VNP 的法规描述为降低了他们使用该设备作为戒烟辅助手段的愿望。许多试图减少或戒烟的参与者同时表示,仅凭 VNP 不足以帮助他们减少或戒烟。

结论

由于 VNP 具有满足尼古丁渴望和行为习惯的独特能力,因此 VNP 有望成为 AOD 治疗人群中的戒烟辅助工具。然而,还需要解决多种障碍,例如可及性、维护和同时减少其他物质使用的挑战,以便最佳地参与 VNP 戒烟的临床试验。

更新日期:2021-09-15
down
wechat
bug